Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: StaggerLee who wrote (2346)	5/24/1999 10:22:00 PM
From: Terry D.	Read Replies (1) \| Respond to of 2395

just until they released another 250 million shares or so. It's amazing how the MM can move this stock. Every time BILCO releases another few hundred million shares the MM go to work and, to my horror, manage to suck in a few hundred more investors. They make Gordon Gecco look like a humanitarian. L. SYBD currently is developing three products: Oxycyte , a perfluorocarbon-based blood substitute; Fluorovent, a perfluorocarbon liquid ventilation product; and an implantable glucose biosensor for continuous monitoring of blood glucose levels in diabetics. Additionally, the company recently announced its intention to form a new venture to acquire therapeutic nitric oxide technology.